Biophytis(BPTSY)
$0.300.00 (0.00%)
BPTSY
Biophytis financials statements
$0.30
At close:0.00 (0.00%)
Want to see BPTSY full AI Analyst Report?
Biophytis (BPTSY) Ratios
41 Followers
Biophytis Ratios
BPTSY's free cash flow for Q4 2024 was €-2.68M. For the 2024 fiscal year, BPTSY's free cash flow was increased by €9.00K and operating cash flow was €-2.78B. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.25 | 0.72 | 0.96 | 1.38 | 1.05 |
| Quick Ratio | 0.25 | 0.72 | 0.88 | 1.41 | 1.05 |
| Cash Ratio | 0.00 | 0.45 | 0.57 | 1.05 | 0.26 |
| Solvency Ratio | -0.61 | -1.04 | -0.99 | -1.01 | -1.24 |
| Operating Cash Flow Ratio | -0.55 | -1.04 | -0.98 | -1.04 | -0.43 |
| Short-Term Operating Cash Flow Coverage | -0.96 | -2.59 | -2.54 | -2.01 | -0.75 |
| Net Current Asset Value | € -12.68M | € -7.00M | € -5.32M | € 809.00K | € 3.63M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.43 | 0.69 | 0.55 | 0.46 | 0.33 |
| Debt-to-Equity Ratio | -1.02 | -2.14 | -6.45 | 2.85 | 3.96 |
| Debt-to-Capital Ratio | 56.56 | 1.87 | 1.18 | 0.74 | 0.80 |
| Long-Term Debt-to-Capital Ratio | -0.07 | -4.17 | 1.82 | 0.43 | 0.44 |
| Financial Leverage Ratio | -0.71 | -3.10 | -11.70 | 6.21 | 11.84 |
| Debt Service Coverage Ratio | -0.78 | -1.97 | -2.51 | -1.77 | -0.78 |
| Interest Coverage Ratio | -5.56 | -11.46 | -14.57 | -6.05 | -3.19 |
| Debt to Market Cap | 0.63 | 2.46 | 1.83 | 0.29 | 0.19 |
| Interest Debt Per Share | 2.19 | 70.16 | 317.66 | 714.61 | 910.07 |
| Net Debt to EBITDA | -1.18 | -0.20 | -0.05 | 0.27 | -0.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 99.94% | 91.60% | 100.00% | 99.73% | 100.00% |
| EBT Per EBIT | 122.18% | 129.68% | 104.06% | 116.53% | 183.02% |
| Return on Assets (ROA) | -150.38% | -142.36% | -110.14% | -85.94% | -93.78% |
| Return on Equity (ROE) | 107.35% | 441.43% | 1288.77% | -534.07% | -1109.92% |
| Return on Capital Employed (ROCE) | 97.63% | 3539.01% | -881.85% | -199.34% | -325.06% |
| Return on Invested Capital (ROIC) | -2242.74% | -285.79% | -223.81% | -106.56% | -79.63% |
| Return on Tangible Assets | -241.88% | -182.62% | -125.26% | -93.01% | -103.99% |
| Earnings Yield | -67.03% | -518.25% | -379.89% | -56.24% | -31.93% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.15 | 0.07 | 0.04 | 0.04 |
| Inventory Turnover | 0.00 | 0.00 | 0.31 | -0.44 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -2450.91 | -4046.67 | -9758.76 | -10409.02 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 1187.00 | -832.11 | 0.00 |
| Days of Payables Outstanding | 0.00 | 2450.91 | 5233.68 | 8926.66 | 10409.02 |
| Operating Cycle | 0.00 | 0.00 | 1187.00 | -832.11 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.67 | -94.86 | -439.54 | -806.61 | -666.49 |
| Free Cash Flow Per Share | -1.67 | -96.48 | -442.80 | -818.27 | -680.95 |
| Dividend Paid and CapEx Coverage Ratio | -0.90 | -58.51 | -134.67 | -69.17 | -46.09 |
| Capital Expenditure Coverage Ratio | -0.90 | -58.51 | -134.67 | -69.17 | -46.09 |
| Operating Cash Flow Coverage Ratio | -0.88 | -1.56 | -1.57 | -1.43 | -1.08 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -55.82% | -398.54% | -300.09% | -43.56% | -12.61% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.49 | -0.19 | -0.26 | -1.78 | -3.13 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -1.60 | -0.85 | -3.39 | 9.50 | 34.76 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.79 | -0.25 | -0.33 | -2.30 | -7.93 |
| Price-to-Operating Cash Flow Ratio | -1.79 | -0.26 | -0.34 | -2.33 | -8.10 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.00 | 0.01 | 0.05 | 0.05 |
| Enterprise Value Multiple | -3.06 | -0.43 | -0.33 | -1.82 | -6.09 |
| Enterprise Value | 25.25M | 5.99M | 7.45M | 48.14M | 83.17M |
| EV to EBITDA | -3.06 | -0.43 | -0.33 | -1.82 | -6.09 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -2.92 | -0.46 | -0.39 | -1.99 | -8.25 |
| EV to Operating Cash Flow | -2.92 | -0.47 | -0.39 | -2.02 | -8.43 |
| Tangible Book Value Per Share | -2.37 | -48.09 | -105.69 | 99.93 | 281.01 |
| Shareholders’ Equity Per Share | -1.86 | -28.42 | -43.50 | 197.80 | 155.34 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.08 | 0.00 | -0.07 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -2.00 | -125.47 | -560.56 | -1056.37 | -1724.12 |
| Tax Burden | 1.00 | 0.92 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.22 | 1.30 | 1.04 | 1.17 | 1.83 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.83 | 0.76 | 0.78 | 0.76 | 0.58 |
Currency in EUR

